Results 221 to 230 of about 25,226 (299)

The Ketogenic Diet in Type 2 Diabetes and Obesity: A Narrative Review of Clinical Evidence. [PDF]

Nutrients
Kilian J, Szlęzak D, Tyszka-Czochara M, Filipowicz-Popielarska E, Bronowicka-Adamska P.   +4 more
europepmc   +1 more source

The Effect of an Autoimmune Protocol (AIP) Diet in Adults With Rheumatoid Arthritis: A Single Arm Crossover Pilot Feasibility Study

Musculoskeletal Care, Volume 24, Issue 2, June 2026.
ABSTRACT Background Individuals with rheumatoid arthritis (RA) often ask whether dietary changes or food exclusions can reduce symptoms. The Autoimmune Protocol (AIP) diet, an elimination‐based approach, is popular on social media, with anecdotal reports of benefit, but lacks clinical evaluation in RA.
Julianne J. McNeill, Gael J. Mearns, Rebecca Grainger, Caryn Zinn   +3 more
wiley   +1 more source

The effects of ketogenic diet and calorie-restricted diet on metabolic dysfunction-associated steatotic liver disease: a retrospective study. [PDF]

Front Nutr
Sun WJ, Xing LL, Zhao SF, Ying HM.
europepmc   +1 more source

Aerobic Exercise Plus Hypocaloric Diet on Serum Leptin Concentrations in Adults With Primary Hypertension and Overweight/Obesity: Results From the EXERDIET‐HTA Trial

Clinical Obesity, Volume 16, Issue 3, June 2026.
Aerobic exercise plus hypocaloric diet on serum leptin concentrations in adults with primary hypertension and Overweight/Obesity. ABSTRACT Hyperleptinaemia is an emerging mechanism involved in the pathogenesis of obesity‐related primary hypertension (HTN).
Virginia A. Aparicio, Pablo Corres, Ilargi Gorostegi‐Anduaga, Javier Margareto, Sara Maldonado‐Martín   +4 more
wiley   +1 more source

Editorial: Integrating ketogenic diet with physical exercise: implications for athletes and chronic conditions. [PDF]

Front Nutr
Cannataro R, Bonilla DA, Caroleo MC, Cerullo G, Kreider RB, Cione E.   +5 more
europepmc   +1 more source

From Pharmacodynamic Biomarker to Evaluating Treatment Response: Biomarkers in Primary Mitochondrial Diseases

Clinical and Translational Science, Volume 19, Issue 6, June 2026.
ABSTRACT Primary mitochondrial diseases (PMDs) result from genetic variants in nuclear DNA and mitochondrial DNA which commonly lead to aberrant oxidative phosphorylation. The clinical complexity, often attributed to the underlying genetics, includes several distinct syndromes (e.g., Barth syndrome; Pearson syndrome; Mitochondrial encephalomyopathy ...
Sydney Stern, Karryn Crisamore, John Patton, Robert Schuck, Michael Pacanowski   +4 more
wiley   +1 more source

The Hypometabolic State of the Migraine Brain: Is a Ketogenic Diet the Answer? [PDF]

Brain Behav
Gunasekera L, Ray JC, Butzkueven H, O'Brien TJ, Hutton E, Kaul N.   +5 more
europepmc   +1 more source

Intravenous immunoglobulin and febrile status epilepticus in children with Dravet syndrome: A retrospective multicentre study

Developmental Medicine &Child Neurology, Volume 68, Issue 6, Page 857-863, June 2026.
This multicenter retrospective study evaluated the use of intravenous immunoglobulin (IVIG) in 14 children with Dravet syndrome as a preventive strategy against febrile status epilepticus. Over a 6‐month period, IVIG was associated with a significant reduction in hospitalizations for febrile status epilepticus.
Romane Marc, Nicole Chemaly, Mathieu Kuchenbuch, Caroline Espil‐Taris, Elodie Lametery, Hélène Maurey, Sylviane Peudenier, Sylvie Nguyen The Tich, Rima Nabbout, Claire Bar   +9 more
wiley   +1 more source

Exploring the role of gut microbiota in potential mechanism of ketogenic diet in alleviating Parkinson's disease symptoms. [PDF]

Front Neurosci
Luo XM, Luo J, Zhang Q, Zeng LY, Liu B, Chi CL.   +5 more
europepmc   +1 more source

Caring for Australians and New ZealandeRs with kidney Impairment guideline commentary on kidney disease: improving global outcomes 2025 guidelines for diagnosis and management of autosomal polycystic kidney disease

Internal Medicine Journal, Volume 56, Issue 6, Page 1068-1073, June 2026.
Abstract Autosomal polycystic kidney disease (ADPKD) is the most common form of inherited kidney disease. The international guideline developer, Kidney Disease: Improving Global Outcomes (KDIGO), published a 2025 clinical practice guideline reflecting advances in genetic testing and the first disease‐modifying agent, tolvaptan.
Mia E. Abdy, Kitty St Pierre, Emily Major, Stephen I. Alexander, Brydee Cashmore, Helen Coolican, Vanessa Cullen, Jessica Dawson, Kelly Lambert, Vincent W. Lee, Amali Mallawaarachi, Gopala Rangan, Judy Savige, Santosh Varughese, David J. Tunnicliffe, Andrew J. Mallett, on behalf of the CARI Guidelines Steering Committee, Emily See, Leanne Brown, Jonathan Craig, Jeffrey Ha, Rathika Krishnasamy, Casey Light, Emmy O'Neill, Thu Nguyen, Hannah Smith, Andrea Viecelli   +26 more
wiley   +1 more source